Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Find news

All 400 news items, newest first.

Free to read, “May need a subscription” and “Archived copy”: what they mean

Whether an article is free to read is a guess, not a test of your access. Each item is one of three:

  • No label: free to read (341 of 400). The publisher’s page marks it free, or the outlet publishes free to read: Medical Xpress, ScienceDaily, NIH (incl. NIA and PMC), Alzheimer's Association, Alzheimer's News Today, NPR, Alzheimer's Disease International, or a .gov site.
  • May need a subscription (15 of 400). The publisher’s own page marks the article as not free to read, or — when the page says nothing — the outlet sells subscriptions: The New York Times, STAT, Scientific American, The Washington Post, The Wall Street Journal, Financial Times, The Economist, Bloomberg, The Atlantic, The New Yorker, Wired, Los Angeles Times, The Boston Globe, The Times, The Telegraph, New Scientist, Endpoints News, Science. Each badge says which.
  • “Free to read? Not known” (44 of 400). The outlet is on neither list and its page said nothing. We do not call these paywalled.

Archived copy links go to a copy the Internet Archive (web.archive.org) saved, dated the day it was saved. We show one only where the Internet Archive reported a working saved copy when we checked; an archived copy of a subscription article sometimes shows only its opening. 288 of 400 items have one.

Glucosamine, a popular joint supplement, linked to faster Alzheimer’s progression

ScienceDaily

A large health-record analysis found that glucosamine use was associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia. …

Read at ScienceDaily → Archived copy (4 Oct 2026), Internet Archive

Scientists found a surprising driver of Alzheimer’s outside the brain

ScienceDaily Research

Scientists found that immune cells contributing to Alzheimer’s-related brain damage may be activated in lymph nodes outside the brain before traveling into the nervous system. …

Read at ScienceDaily → Archived copy (28 Sep 2026), Internet Archive

The brain still responds to favorite music in dementia

Medical Xpress Research

What happens in the brain of someone with dementia when they hear music that means something to them? Researchers from Alzheimer Center Amsterdam and the Netherlands Institute for Neuroscience mapped how the brain responds to personally meaningful music. …

Why it matters: Researchers mapped how the brain of someone with dementia responds when hearing personally meaningful music.

Read at Medical Xpress → Archived copy (28 Sep 2026), Internet Archive

Menopause leaves a fingerprint that may predict dementia risk

Medical Xpress Research

As women go through menopause, they often sense that it's not just their bodies changing, but also their minds. They report hot flashes, anxiety, brain fog and trouble sleeping—all symptoms that can be traced back to the brain.

Why it matters: As women undergo menopause, they report symptoms such as brain fog, anxiety, and trouble sleeping, which can all be traced back to changes in the brain.

Read at Medical Xpress → Archived copy (2 Oct 2026), Internet Archive

Solving Alzheimer's with math? Researcher explores the possibilities

Medical Xpress Research

What can mathematics reveal about Alzheimer's disease? Mississippi State University associate professor Shantia Yarahmadian is using mathematical modeling to examine how common metals may influence a protein that forms plaque associated with Alzheimer's disease…

Why it matters: Mississippi State University researcher Shantia Yarahmadian is using mathematical modeling to examine how common metals may influence a protein linked to Alzheimer's disease plaque.

Read at Medical Xpress →

How the MIND diet protects aging brains

Medical Xpress Research

A well-known brain-healthy diet may help ward off cognitive decline and dementia by protecting arteries, a new study suggests.

Why it matters: A well-known brain-healthy diet may help ward off cognitive decline and dementia by protecting arteries, a new study suggests.

Read at Medical Xpress →

Can hormone replacement therapy prevent dementia? What the latest research tells us

Medical Xpress Research

A study has raised a question that many women would understandably want answered: Could hormone replacement therapy (HRT) protect against dementia? …

Why it matters: A study raised a key question about whether hormone replacement therapy (HRT) could help protect women against dementia.

Read at Medical Xpress →

Acadia misses mark in Alzheimer’s but concludes phase 3 ‘absolutely worth’ pursuing

Fierce Biotech Research

Acadia Pharmaceuticals’ phase 2 Alzheimer’s disease trial has missed its primary endpoint, but the company and analysts alike saw enough encouraging signals to support the continuation of a phase 3 program.

Free to read? Not known for this outlet.

Read at Fierce Biotech → Archived copy (25 Sep 2026), Internet Archive

Blood proteins shift during Alzheimer's treatment and may help monitor the effects of the medication

Medical Xpress Research

Patients with early symptoms of Alzheimer's disease may be prescribed anti-amyloid therapy, which can help clear the sticky clumps of amyloid protein in the brain that characterize Alzheimer's. …

Why it matters: Shifts in blood proteins during Alzheimer's treatment may help monitor the effects of medication in patients receiving anti-amyloid therapy.

Read at Medical Xpress →

Scientists develop high-resolution molecular maps of Alzheimer’s and related brain disorders

NIH News Releases Diagnosis

NIH-funded effort delivers new insights into symptoms and underlying mechanisms of these conditions to improve prevention, detection, treatment, and outcomes.

Cited in this article, summarized in alzhub's library:
Read at NIH News Releases → Archived copy (27 Sep 2026), Internet Archive

Scientists restore a brain protein and reverse signs of aging in mice

ScienceDaily Research

Scientists found that declining levels of the brain protein Menin may help drive aging, with lower levels in mice linked to inflammation, cognitive decline, weaker bones, and thinner skin. …

Read at ScienceDaily → Archived copy (1 Oct 2026), Internet Archive

Scientists discover a major brain shift between ages 50 and 75

ScienceDaily Research

Scientists have uncovered sweeping changes in how the human brain controls and organizes its genome beginning in midlife, offering new clues to why aging sharply increases the risk of Alzheimer’s and other neurodegenerative diseases. …

Read at ScienceDaily → Archived copy (21 Sep 2026), Internet Archive

Scientists find a new layer of Alzheimer’s hidden in the genome

ScienceDaily Research

Scientists found that the 3D organization of DNA is disrupted in several types of brain cells affected by Alzheimer’s disease, altering how important genes are switched on and off. …

Read at ScienceDaily → Archived copy (20 Sep 2026), Internet Archive

Early statin use linked to 15% lower dementia risk

ScienceDaily Diagnosis

Starting statins soon after a type 2 diabetes diagnosis may do more than protect the heart. In a nationwide Danish study of more than 132,000 people…

Read at ScienceDaily → Archived copy (18 Sep 2026), Internet Archive

At-home injection version of Alzheimer’s drug now available in US

Alzheimer's News Today

In the U.S., people with early Alzheimer’s disease will now have the option for at-home treatment with the approved therapy Leqembi (lecanemab) throughout the entire treatment journey. …

Read at Alzheimer's News Today → Archived copy (2 Oct 2026), Internet Archive

Alzheimer’s may leave a mark on the brain long before plaques appear

ScienceDaily Diagnosis

Brain changes associated with Alzheimer’s may begin at least seven years before amyloid plaques become detectable with current PET scans. Researchers uncovered the signal by tracking healthy older adults with repeated brain imaging over nearly 20 years. …

Read at ScienceDaily → Archived copy (16 Sep 2026), Internet Archive

Reaching 90 without dementia doesn’t mean you’re in the clear

ScienceDaily Research

A study of people over 90 found that dementia risk remains strongly shaped by sex, race and genetics, with women and black participants facing notably higher risks. …

Read at ScienceDaily → Archived copy (6 Sep 2026), Internet Archive

Your sleep may be hiding an early clue to Alzheimer’s

ScienceDaily

Frequent micro-awakenings during sleep were linked to higher genetic risk for Alzheimer’s in healthy middle-aged adults who had no symptoms. …

Read at ScienceDaily → Archived copy (28 Sep 2026), Internet Archive

This common vitamin was linked to 13% better cognitive scores

ScienceDaily

Older adults with mild cognitive impairment and sleep problems who took at least 5,000 IU of vitamin D daily scored more than 13% higher on a cognitive test than those taking none. …

Read at ScienceDaily → Archived copy (4 Oct 2026), Internet Archive

A major Alzheimer’s risk gene may shrink brain cells years before symptoms

ScienceDaily Research

Researchers have uncovered a possible reason why the Alzheimer’s risk gene APOE4 can disrupt the brain long before memory problems begin. In mice, APOE4 increased a protein called Nell2, shrinking neurons and making memory circuits unusually active. …

Read at ScienceDaily → Archived copy (1 Oct 2026), Internet Archive

FDA Clears C2N Diagnostics' PrecivityAD2 — First Alzheimer's Blood Test for Adults With Cognitive Symptoms as Young as 40

C2N Diagnostics (via BioSpace) Diagnosis

The FDA cleared C2N Diagnostics' PrecivityAD2 mass-spectrometry blood test for adults as young as 40 with signs of cognitive impairment, showing 97.6% positive predictive value and 93.1% negative predictive value for amyloid pathology in a 1,142-person study.

Why it matters: Extends FDA-cleared blood testing to younger patients with early symptoms, broadening options beyond the Fujirebio test and expanding access to earlier, less invasive diagnosis.

Free to read? Not known for this outlet.

Read at C2N Diagnostics (via BioSpace) → Archived copy (7 Oct 2026), Internet Archive

A little-known protein may be fueling Alzheimer’s — and scientists found a way to block it

ScienceDaily Research

An experimental Alzheimer’s compound prevented damaging protein clumps from forming in the brains of mice, helping nerve cells survive longer and reducing amyloid buildup. …

Read at ScienceDaily →

A little movement in midlife could pay off for your brain years later

ScienceDaily

Exercise and healthy blood sugar levels in midlife may help slow cognitive decline decades later. Physical activity appeared especially beneficial for Mexican American adults, suggesting that some brain-protective factors may differ across populations.

Read at ScienceDaily → Archived copy (17 Aug 2026), Internet Archive

Women taking estrogen had fewer signs of Alzheimer’s in their brains

ScienceDaily Research

Women who used estrogen-only hormone therapy later in life were less likely to develop dementia and showed fewer signs of Alzheimer’s disease in their brains, according to a large study of more than 21,000 participants. …

Read at ScienceDaily → Archived copy (3 Oct 2026), Internet Archive

Nearly half of dementia cases may be linked to risks you can change

ScienceDaily Research

A long-term brain study found that common risks such as smoking, high blood pressure, heart disease, and high blood lipids were strongly linked to damage associated with vascular dementia. …

Read at ScienceDaily → Archived copy (15 Sep 2026), Internet Archive

Scientists discover a hidden brain shift that begins around age 50

ScienceDaily Research

Beginning around age 50, the brain’s memory center appears to lose many of its longtime immune cells and replace them with more inflammatory ones. This surprising shift may help explain how normal aging sets the stage for Alzheimer’s disease and dementia.

Read at ScienceDaily → Archived copy (27 Sep 2026), Internet Archive

FDA designation may speed new treatment for Alzheimer’s psychosis

Alzheimer's News Today

The U.S. Food and Drug Administration (FDA) has granted fast track designation to remlifanserin, an experimental treatment that Acadia Pharmaceuticals is developing for hallucinations and delusions associated with Alzheimer’s disease psychosis. …

Read at Alzheimer's News Today →

AI can tell if your brain is aging faster than you are

ScienceDaily Research

A person’s sleeping brain may reveal warning signs of dementia long before memory problems begin. Researchers used machine learning to analyze EEG recordings from about 7,000 adults and found that an older-than-expected “brain age” was tied to a sharply higher dementia risk. …

Read at ScienceDaily → Archived copy (5 Oct 2026), Internet Archive

Scientists discover why poor sleep may harm some brains more

ScienceDaily Research

A gene involved in the brain’s overnight cleaning system may change how strongly poor sleep affects Alzheimer’s-related brain changes. The findings point toward more personalized prevention strategies based on both genetics and sleep habits.

Read at ScienceDaily → Archived copy (1 Aug 2026), Internet Archive

Scientists discover how obesity may fuel Alzheimer’s disease

ScienceDaily Research

Researchers have uncovered a possible biological pathway connecting obesity to Alzheimer’s disease. Obesity appears to raise levels of certain fat molecules that can travel to the brain, disrupt its immune defenses, and promote harmful amyloid buildup. …

Read at ScienceDaily →

Last updated